ALPHA TEKNOVA, INC. Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest
ALPHA TEKNOVA, INC. (TKNO) reported Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest of -$47.47 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-30.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest · last filed 2023-03-30
- ALPHA TEKNOVA, INC. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2022-12-31 was -$13.29M.
- ALPHA TEKNOVA, INC. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2022-09-30 was -$22.47M.
- ALPHA TEKNOVA, INC. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2022-06-30 was -$6.20M.
- ALPHA TEKNOVA, INC. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2022-03-31 was -$5.50M.
- ALPHA TEKNOVA, INC. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2022 was -$47.47M.
- ALPHA TEKNOVA, INC. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2021 was -$9.81M, a 375.79% decline from fiscal 2020.
- ALPHA TEKNOVA, INC. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2020 was $3.56M.
| Period end | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$13.29M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$35.77M derived: sum of 2 quarters · filed 2023-03-30 | -$41.97M derived: sum of 3 quarters · filed 2023-03-30 | -$47.47M 10-K · filed 2023-03-30 |
| 2022-09-30 | -$22.47M 10-Q · filed 2022-11-14 | -$28.68M derived: sum of 2 quarters · filed 2022-11-14 | -$34.17M 10-Q · filed 2022-11-14 | -$37.82M derived: sum of 4 quarters · filed 2023-03-30 |
| 2022-06-30 | -$6.20M 10-Q · filed 2022-08-11 | -$11.70M 10-Q · filed 2022-08-11 | -$15.35M derived: sum of 3 quarters · filed 2023-03-30 | -$18.60M derived: sum of 4 quarters · filed 2023-03-30 |
| 2022-03-31 | -$5.50M 10-Q · filed 2022-05-12 | -$9.14M derived: sum of 2 quarters · filed 2023-03-30 | -$12.39M derived: sum of 3 quarters · filed 2023-03-30 | -$14.64M derived: sum of 4 quarters · filed 2023-03-30 |
| 2021-12-31 | -$3.65M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$6.90M derived: sum of 2 quarters · filed 2023-03-30 | -$9.15M derived: sum of 3 quarters · filed 2023-03-30 | -$9.81M 10-K · filed 2023-03-30 |
| 2021-09-30 | -$3.25M 10-Q · filed 2022-11-14 | -$5.50M derived: sum of 2 quarters · filed 2022-11-14 | -$6.16M 10-Q · filed 2022-11-14 | -$5.58M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$2.25M 10-Q · filed 2022-08-11 | -$2.91M 10-Q · filed 2022-08-11 | -$2.33M derived: sum of 3 quarters · filed 2022-08-11 | -$810.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | -$648.00K 10-Q · filed 2022-05-12 | -$83.00K derived: sum of 2 quarters · filed 2022-05-12 | $1.44M derived: sum of 3 quarters · filed 2022-05-12 | $2.00M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $565.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | $2.09M derived: sum of 2 quarters · filed 2022-03-18 | $2.64M derived: sum of 3 quarters · filed 2022-03-18 | $3.56M 10-K · filed 2022-03-18 |
| 2020-09-30 | $1.52M 10-Q · filed 2021-11-12 | $2.08M derived: sum of 2 quarters · filed 2021-11-12 | $2.99M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $555.00K 10-Q · filed 2021-08-13 | $1.47M 10-Q · filed 2021-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |